25 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
8-K
EX-10.1
mjl4217dox1ew0oh160
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-1.1
nf2 0ok3q3u13i90
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
lwqi00 ffbxqduv
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
424B4
83all
5 Oct 20
Prospectus supplement with pricing info
4:16pm
8-K
EX-10.1
q3crioaxd634f6r
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
424B3
q1j3bukalis36jk2sj3
9 Nov 18
Prospectus supplement
5:04pm